发明名称 |
(r)-7-(2-(1-(4-butoxifenil)-2-metilpropan-2-ilamino)-1-hidroxietil)-5-hidroxibenzo[d]tiazol-2(3h)-ona; proceso de preparacion; composicion y combinacion farmaceutica que lo comprende; y uso en el tratamiento y prevencion de la distrofia muscular, atrofia por desuso, caquexia o sarcopenia. |
摘要 |
The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions. |
申请公布号 |
CL2014000493(A1) |
申请公布日期 |
2014.10.03 |
申请号 |
CL20140000493 |
申请日期 |
2014.02.27 |
申请人 |
NOVARTIS AG |
发明人 |
NICOLA TUFILLI;JUN CAO;BERNHARD ERB;ROBIN ALEC FAIRHURST;ARNAUD GRANDEURY;SHINJI HATAKEYAMA;MAGDALENA KOZICZAK-HOLBRO;XINZHONG LAI;PHILIPP LUSTENBERGER;THOMAS ULLRICH;XIANG WU;JIANGUANG ZHOU;BERN RIEBESEHL |
分类号 |
C07D277/68;A61K31/428;A61P21/00 |
主分类号 |
C07D277/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|